Genmab A/S Adjustments For Increase Decrease In Other Liabilities
Genmab A/S (GNMSF) reported Adjustments For Increase Decrease In Other Liabilities of $400.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities · last filed 2026-02-17
DKK
| Period end | Adjustments For Increase Decrease In Other Liabilities 6 month | Adjustments For Increase Decrease In Other Liabilities 12 month |
|---|---|---|
| 2024-12-31 | 857.00M DKK 6-K · filed 2025-02-12 | |
| 2024-06-30 | 758.00M DKK 6-K · filed 2024-08-08 | |
| 2023-12-31 | 622.00M DKK 6-K · filed 2025-02-12 | |
| 2023-06-30 | 171.00M DKK 6-K · filed 2024-08-08 | |
| 2022-12-31 | 283.00M DKK 6-K · filed 2025-02-12 |
USD
| Period end | Adjustments For Increase Decrease In Other Liabilities 6 month | Adjustments For Increase Decrease In Other Liabilities 12 month |
|---|---|---|
| 2025-12-31 | $400.00M 20-F · filed 2026-02-17 | |
| 2025-06-30 | $51.00M 6-K · filed 2025-08-07 | |
| 2024-12-31 | $122.00M 20-F · filed 2026-02-17 | |
| 2024-06-30 | $109.00M 6-K · filed 2025-08-07 | |
| 2023-12-31 | $90.00M 20-F · filed 2026-02-17 |